NEW YORK--(BUSINESS WIRE)--LifeSci Advisors, LLC, a leading provider of investment research and investor relations services in the life sciences sector, today announced that it has initiated coverage of Bionovo, Inc. (Nasdaq: BNVI), a clinical stage drug discovery and development company focused on safe and effective treatments for women’s health and cancer. The company applies its expertise in the biology of menopause and cancer to design new drugs with novel mechanisms of action, utilizing botanical sources known from traditional Chinese medicine.
